Maximally Tolerated Dose (Mtd) and 14-Day Dose Range-Finding (Drf) Toxicity Study... Tender

Procurement Summary

Country : USA

Summary : Maximally Tolerated Dose (Mtd) and 14-Day Dose Range-Finding (Drf) Toxicity Study in Male and Female Rats for Ncats Etb.

Deadline : 09 Aug 2023

Other Information

Notice Type : Tender

TOT Ref.No.: 86694362

Document Ref. No. : 75N95023Q00536

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Description

COMBINED SYNOPSIS / SOLICITATION

75N95023Q00536





TITLE: Maximally tolerated dose (MTD) and 14-Day Dose Range-Finding (DRF) Toxicity Study in Male and female rats for NCATS ETB.



(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotations are being requested and a written solicitation will not be issued.



(ii) The solicitation number is 75N95023Q00536 and the solicitation is issued as a request for quotation (RFQ). This acquisition is for a commercial item and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13 - Simplified Acquisition Procedures and FAR Part 12 - Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold.



(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2023-04, effective June 2, 2023.



(iv) The associated NAICS code is 541380 and the Small Business size standard is $19M. This requirement is non-competitive and no set-aside restrictions are applicable.



THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).



The National Institute on Drug Abuse (NIDA), Office of Acquisition (OA), on behalf of the National Center for Advancing Translational Sciences (NCATS), intends to negotiate and award a purchase order without providing for full and open competition (including brand-name) to Pharmaron, Inc., 201 E Jefferson St., Louisville, KY 40202-1246. To ensure consistency among data, the current study must be conducted by the same vendor that conducted prior studies. Therefore, to ensure the continuity of scie...
Active Contract Opportunity
Notice ID : 75N95023Q00536
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : NATIONAL INSTITUTES OF HEALTH
Office : NATIONAL INSTITUTES OF HEALTH NIDA
General Information
Contract Opportunity Type: Combined Synopsis/Solicitation (Updated)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Updated Published Date: Aug 03, 2023 07:54 am EDT
Original Published Date: Jul 31, 2023 09:38 am EDT
Updated Date Offers Due: Aug 09, 2023 03:00 pm EDT
Original Date Offers Due: Aug 03, 2023 03:00 pm EDT
Inactive Policy: 15 days after date offers due
Updated Inactive Date: Aug 24, 2023
Original Inactive Date: Aug 18, 2023
Initiative: None

Classification
Original Set Aside:

Product Service Code: Q301 - MEDICAL- LABORATORY TESTING
NAICS Code: 541380 - Testing Laboratories and Services

Place of Performance: USA

Documents

 Tender Notice

1-SOW.pdf

2-VAS-Worksheet.pdf

3-FAR-52.204-24-Nov-2021.pdf

4-FAR-52.204-26-Oct-2020.pdf

5-FAR-52.212-5-Jun-2023.pdf

6-FAR_52.212-4_Addendum_Nov_2021.pdf

7-Invoicing-Instructions-With-IPP-3-23-1.pdf